drugset / Trial / NCT00491413
Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth
Phase 1
Unknown
15 enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Erythropoietin (Epo) is a hormone normally found in the body that may protect brain cells from damage due to lack of oxygen. This study will evaluate the safety of high-dose Epo in infants who did not get enough oxygen during birth.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | — | Intravenous |